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The study was aimed to investigate the impact of using standard cri-
teria for assessing specimen adequacy and diagnostic terminology
(CAST) on fine-needle aspiration (FNA) diagnosis and clinical man-
agement of thyroid nodules. The study included similar numbers of
FNAs performed in 2 year before (group A) and 1.5 year after
(group B) implementing the standard CAST. In comparison to group
A, group B showed a significantly lower rate of nondiagnostic speci-
mens (RND) (16.1% vs. 21.6%, P  0.01) and rate of descriptive
diagnoses (RDD) (3.8% vs. 14.5%, P  0.001) and greater non-neo-
plastic (70.0% vs. 64.1%, P < 0.05) and follicular cell lesions (7.4%
vs. 4.3%, P < 0.05) but a similar percentage of neoplastic diagnoses.
The rate of surgical follow-up (RSF) was significantly higher in
group B than in group A, overall (21.6% vs. 17.0%, P < 0.05), or in
subgroups of non-neoplastic (12.6% vs. 5.4%, P < 0.01) and neo-
plastic categories (81.0% vs. 61.0%, P < 0.05). The rate of cytohis-
tologic concordance was higher in group B although the difference
was not statistically significant. We concluded that use of the stand-
ard CAST on FNA diagnosis of thyroid nodules significantly reduced
RND and RDD, providing more consistent diagnoses among the
pathologists as well as better and more uniform communication
between the pathologists and the clinicians. Furthermore, the cyto-
histological concordance was slightly better after CAST implementa-
tion, indicating that the improvement of diagnostic consistency
among pathologists did not sacrifice the diagnostic accuracy. Diagn.
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Fine-needle aspiration (FNA) is a widely used triage
procedure in the management of thyroid nodules, which
aims to distinguish nodular lesions that require surgical
intervention from those that may be managed conserva-
tively with clinical and imaging follow-up.1–4 As previ-
ously reported, on-site assessment of specimen adequacy
has played an important role with respect to a decreased
nondiagnostic rate and an increased diagnostic yield of
FNA of thyroid nodules.5–9 Various criteria for ade-
quacy assessment are used not only among institutions10
but also among pathologists in the same institution.6
In this regard, some require six or more cell groups
comprising of 10–20 cells per group on two separate
slides5 and others require no less than six clusters con-
taining at least 10–12 follicular cells each.8,11 Further-
more, it is noted that different diagnostic categories and
terminology are used for cytological diagnosis of thy-
roid nodules.6,8,11,12
In our institution, lack of uniform criteria for ade-
quacy assessment and diagnostic terminology created
diagnostic inconsistency between pathologists and diffi-
cult communications with clinicians. This prompted the
development of standard criteria for assessment of speci-
men adequacy and terminology (CAST). The standard
CAST was distributed and explained to all involved
parties including endocrinologists, radiologists, and sur-
geons and has been implemented in our cytology prac-
tice since 2005. This study was carried out to investi-
gate the impact of using the standard CAST on FNA
diagnosis and clinical management of thyroid nodules.
Materials and Methods
The study included FNA specimens obtained from
two individual periods, 2 years (January 2003–December
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2004) prior to and one and a half years (January 2005–
June 2006) after implementing the standard CAST. Path-
ologists involved in cytopathology service included the
same seven individuals for both periods, although two of
them were replaced in late period B by a new pathologist,
all had similar levels of experience and subspecialty train-
ing in evaluating thyroid FNA. Overall, the staffing is not
considered to have changed significantly. In our institu-
tion, endocrinologists, radiologists, and surgeons per-
formed FNAs with or without ultrasound guidance and
with or without cytopathologist-assisted on-site assess-
ment of specimen adequacy. For FNAs with on-site ade-
quacy assessment, two direct smears were made for each
pass and the needle was then rinsed in CytolytTM solution
for a ThinPrep and/or a cell block. One smear was air-
dried, stained with Diff-Quik stain, and then evaluated
immediately for specimen adequacy. The other smear was
quickly fixed with SprayfixTM and later stained with Papa-
nicolaou stain before examination. For FNAs without on-
site adequacy assessment, each specimen was submitted
in CytolytTM solution from which a ThinPrep and a cell
block slide were prepared.
Our standard CAST defined specimens as adequate by
the presence of at least six groups of follicular cells with
a minimum of 10 cells in each group. Eight FNA diag-
nostic categories (Table I) were established according to
Guidelines of the Papanicolaou Society of Cytopathology
for the Examination of Fine-Needle Aspiration Specimens
from Thyroid Nodules13 with minor modification. An edu-
cational grand round was given to the endocrinologist and
radiologist performing FNA procedures to explain the
terms and meaning of the categories before the implemen-
tation of the CAST. Diagnoses made for adequate speci-
mens without assigned diagnostic categories were termed
as descriptive diagnoses in this study. Exception was
made for suboptimal specimens containing atypical cells
with features suggestive of a neoplasm and a diagnosis
was made as such noting the suboptimal nature of the
specimen regardless of the number of groups of cells.
Cytohistologic correlation was performed for adequate
specimens with categorized diagnoses and available surgi-
cal follow-up.
The parameters including rate of nondiagnostic speci-
men (RND), rate of descriptive diagnoses (RDD), rate of
surgical follow-up (RSF), and rate of concordance (RC)
were calculated as follows:
RND ¼ (inadequate specimens/total specimens) 3
100%
RDD ¼ (diagnostic specimens with descriptive diagno-
ses/total diagnostic specimens) 3 100%
RSF ¼ (diagnostic specimens with surgical follow-up/
total diagnostic specimens) 3 100%
RC ¼ (histology confirmed specimens/specimens with
categorized diagnosis and surgical follow-up) 3 100%.
For the purpose of this study, cytologic diagnoses made
before implementing the standard CAST were converted
to the standard terminology based upon the description
and the same parameters mentioned above were calcu-
lated accordingly. The data generated before (group A)
and after (group B) implementing the standard CAST
were compared by using the v2 test, Fisher exact test, and
unpaired t-test with the help of the SigmaStat.3.5 program
(Systat Software). The level of difference was considered
statistically significant when P  0.05.
Results
A total of 764 specimens from 641 patients in group A
and 824 specimens from 649 patients in group B were
examined. More female than male patients were included
in both group A (female/male ¼ 537/112) and group B
(female/male ¼ 536/105). The gender distributions
between the two groups were not statistically different.
However, the average age of patients in group B (52.6 6
0.6 yr-old) was older (P < 0.001) than those in group A
(49.6 6 0.6 yr-old). A summary of the specimen’s demo-
graphic data is presented in Table II. As noted, specimens
in group B were more frequently prepared with on-site
adequacy assessment compared to those in group A
(64.0% vs. 41.2%, P < 0.001). Significantly lower RND
was achieved in specimens prepared with on-site ade-
quacy assessment than those without on-site adequacy
assessment in both group A (6.7% vs. 32.1%, P < 0.001)
and group B (4.7% vs. 36.3%, P < 0.001). Overall RND
was significantly lower in group B than in group A
(16.1% vs. 21.6%, P < 0.01).
Table I. Diagnostic Category for Thyroid FNA
Interpretations Descriptions
1. Suggestive of colloid nodule Abundant colloid with scant or
without follicular cells
2. Consistent with cyst contents Numerous macrophages without
follicular cells







5. Nodular hyperplasia Six or more follicular cell
clusters, colloid and
histocytes




clusters with little colloid and
equivocal features
7. Follicular/Hurthle cell neoplasm Follicular/Hurthle cell clusters
with loss of honeycombing,
presence of microfollicles and
syncytial sheets, with or
without colloid
8. Positive for malignancy Features consistent with
malignancy
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Table III illustrates distribution of adequate (diagnostic)
specimens among the designated categories, which
included lymphocytic thyroiditis (category 4), non-neo-
plastic (categories 1, 2, 3, 5), neoplastic (categories 7, 8),
and follicular cell lesions (category 6). RDD and RSF are
also presented hereby. Group B had a significantly lower
RDD than group A (3.8% vs. 14.5%, P < 0.001) and all
individuals made fewer numbers of descriptive diagnoses
in group B compared to group A. Although both groups
showed similar percentages in the neoplastic category,
group B revealed a greater percentage than group A
with regard to lymphocytic thyroiditis (7.4% vs. 4.2%,
P < 0.01), non-neoplastic categories (70.0% vs. 64.1%,
P < 0.05), and follicular cell lesions (7.4% vs. 4.3%,
P < 0.05). Surgical follow-up was performed in a total of
102/599 specimens in group A and 149/691 specimens in
group B. The overall RSF was significantly higher in
Group B than in Group A (21.6% vs. 17.0%, P < 0.05).
The same trend was observed in both non-neoplastic
(12.6% vs. 5.4%, P < 0.01) and in neoplastic categories
(81.0% vs. 61.0%, P < 0.05).
Table IV shows cytohistologic correlation in catego-
rized specimens. The overall RC was slightly improved in
group B although the difference did not achieve statistical
Table II. Data of Specimens Before and After Implementation of the Standard CAST
Types of specimen
Number of specimens (%) Nondiagnostic rate
A B A B
With on-site adequacy assessment 315 (41.2) 527 (64.0)a 21 (6.7)b 25 (4.7)b
Without on-site adequacy assessment 449 (58.8) 297 (36.0)a 144 (32.1) 108 (36.3)
Overall 764 (100) 824 (100) 165 (21.6) 133 (16.1)c
Before (A) and after (B) implementing the standard CAST.
aP < 0.001 compared to group A.
bP < 0.001 compared to those without on-site adequacy assessment.
cP < 0.01 compared to group A.
Table III. Cytologic Diagnoses and Surgical Follow-Up
Cytologic diagnosis
Number of specimens (%) Number of specimens with surgical follow-up (%)
A B A B
Lymphocytic thyroiditis 25 (4.2) 51 (7.4)a 4 (16.0) 4 (7.8)
Non-neoplastic 384 (64.1) 484 (70.0)b 22 (5.4) 61 (12.6)a
Neoplastic 77 (12.9) 79 (11.4) 47 (61.0) 64 (81.0)b
FCL (indeterminate) 26 (4.3) 51 (7.4)b 14 (53.8) 18 (35.2)
Descriptive diagnoses 87 (14.5) 26 (3.8)c 15 (17.2) 2 (7.7)
Overall 599 (100) 691 (100) 102 (17.0) 149 (21.6)b
Before (A) and after (B) implementing the standard CAST.
FCL, follicular cell lesions.
aP < 0.01 compared to group A.
bP < 0.05 compared to group A.
cP < 0.001 compared to group A.
















Lymphocytic thyroiditis 4 – – – – 4/4 (100)
Non-neoplastic – 17 4 1 – 17/22 (77.3)
Neoplastic 3 8 – 2 34 36/47 (76.6)
FCL (indeterminate) – 11 – 1 2 12/14 (85.7)
Overall 7 36 4 4 36 69/87 (79.3)
Group B
Lymphocytic thyroiditis 1 2 – – 1 1/4 (25)
Non-neoplastic 1 46 1 – 3 46/5 (190.2)
Neoplastic – 13 3 1 47 51/64 (79.7)
FCL (indeterminate) – 10 4 1 3 15/18 (83.3)
Overall 2 71 8 2 54 113/137 (82.5)
Before (Group A) and after (Group B) the implementation of standard CAST.
FCL, follicular cell lesions.
Data are presented as number (percentage).
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significance between group A (79.3%) and group B
(82.5%). RC was greater in group B than in group A for
both non-neoplastic (other than lymphocytic thyroiditis)
and neoplastic lesions while it appeared to be greater in
group A than group B for lymphocytic thyroiditis,
although the differences were below the level of statistical
significance. For follicular cell lesion cytology diagnoses,
although it can encompass from benign to malignant
lesions, we only considered papillary carcinoma, only two
cases were follicular variant of papillary carcinoma, on
surgical resection as discordant cases with this group.
The RC was similar between group A and group B
(85.7% vs. 83.3%). The difference on overall diagnostic
sensitivity of FNA cytology between group A (58/87 ¼
66.7%) and group B (104/137 ¼ 76.4%) was not signifi-
cantly different.
As shown in Table V, group A had 18 and group B
had 23 discrepant cases. Ten (group A) and 8 (group B)
cases were prepared by ThinPrep, and the remaining 8
(group A) and 15 (group B) cases were prepared by con-
ventional smear. False positive diagnoses of follicular
neoplasm attributed to most of these discrepancies regard-
less the methods of specimen preparation. Histology-con-
firmed neoplasms (adenoma or carcinoma) in a back-
ground of nodular hyperplasia/thyroiditis were seen in 7
cases in group A and 10 cases in group B in which cyto-
logic diagnoses were mostly nodular hyperplasia or thy-
roiditis. The cytohistologic discrepancy was due to sam-
pling error since even a second review of the cytology
slides at the time of this study failed to identify cytologi-
cal features diagnostic for a neoplasm with the knowledge
that the follow-up diagnosis was neoplasm. Cytologic di-
agnosis of follicular neoplasm or papillary carcinoma was
made in 11 cases in group A and 13 cases in group B,
which was found to be non-neoplastic on surgical resec-
tion. This discrepant phenomenon resulted from errors in
overinterpretation of some cytological features in those
benign lesions that could be suggestive but not diagnostic
of neoplasm.
Discussion
This study was carried out to evaluate the impact of using
the standard CAST on FNA diagnosis and clinical man-
agement of thyroid nodules. Our data demonstrates that
use of standard CAST on FNA diagnosis of thyroid nod-
ules has significantly reduced RND and RDD without
influencing the diagnostic concordance rate significantly.
Similar to previously published data,5–9 our results prove
the benefit of performing on-site assessment of specimen
adequacy in FNA diagnosis of thyroid nodules in terms of
a decrease in nondiagnostic rate and an increase in diag-
nostic yield, regardless of the implementation of the
standard CAST.
As previously mentioned, different criteria for specimen
adequacy and diagnostic categories were used for cytolog-
ical diagnosis of thyroid nodules. While assessing
specimen adequacy we acknowledge that the nature of
thyroid lesions should be considered. In this regard, follic-
ular cells may be absent or rare in some benign thyroid
nodules mainly composed of colloid material or under-
going extensive cystic degeneration with or without hem-
orrhage. Large (3cm) and cystic/solid lesions may pre-
dict high prevalence of malignancy.14 We thus used num-
ber of follicular cells as a general rule but not a sole
measurement, and provided suggestive diagnoses (catego-
ries 1–3) while interpreting these specimens which might
be classified as nondiagnostic due to the insufficient num-
ber of follicular cells. This approach proved to be useful
in the appropriate clinical context. Hurthle cell neoplasm
and follicular neoplasm were grouped into one category
in the current study as a previous study conducted in our
institution has indicated that Hurthle cell neoplasm did
not predict more malignant potential compared to follicu-
lar neoplasm.15
During the period in which specimens in group A were
collected, the majority of ultrasound-guided FNAs were
performed by radiologists with only 50% having on-site
assessments performed. In early 2005, the endodocrinolo-
gists became more actively involved in ultrasound-guided
FNAs and were more willing to have a cytopathologist
present for on-site adequacy assessment. This higher per-
centage contributed to the higher on-site adequacy assess-
ment (smear plus ThinPrep/CB) in group B. Despite on-
site adequacy assessment, more diagnostic inconsistency
was encountered in group A due to the lack of the stand-
ard CAST. In this regard, some cases that appeared to be
adequate to one individual at on-site evaluation may be
changed to inadequate by a different individual on final
examination. Further, after implementing the standard
CAST, suggestive diagnoses were generated for speci-
mens from lesions mainly comprised of colloid or cyst,
Table V. Distribution of Discrepant Cases
Cytologic diagnosis







thyroiditis 0 0 1 2
Non-neoplastic 4 1 0 4
FCL (indeterminate) 0 2 1 2
Neoplastic
Follicular
neoplasm 5 4 5 2
Papillary
carcinoma 1 1 1 5
Total 10 8 8 15
Before (Group A) and after (Group B) the implementation of standard
CAST.
FCL, follicular cell lesion.
Data presented as number of cases.
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which might be treated as nondiagnostic previously due
to too few or absence of follicular cells. These factors
contributed to a significant reduction of RND in group B
in which the specimen were interpreted using the standard
CAST.
Although the cost-effectiveness for on-site assessment
of specimen adequacy in FNA of thyroid lesions remains
a controversial issue,6,16 its effect on reducing the non-
diagnostic rate of FNA of thyroid nodules has been
proven.5–9 In this study, data generated from both group
A and B consistently demonstrated a dramatic drop in the
nondiagnostic rate with on-site assessment of specimen
adequacy. Use of uniform criteria was previously recom-
mended,17 however, there is no published data demon-
strating the effect of using a standardized system for
cytologic examination of the thyroid to the best of our
knowledge.
It may be postulated that use of the standard CAST
would reduce the surgical procedure rate as better-defined
criteria for adequacy and diagnosis would reduce the rate
of unnecessary operative procedures while still capturing
all patients needing surgery. On the contrary, the rates of
surgical follow-up for both non-neoplastic and neoplastic
categories, as well as overall RSF were significantly
higher after implementing the standard CAST. This phe-
nomenon may be related to the older age of the patients
in this group or other clinical factors rather than use of
the CAST itself. One reasonable explanation is that less
ambiguous diagnostic languages (lower RDD) coupled
with fewer nondiagnostic specimens in group B prompt
more definitive treatment (surgical) procedure instead of
clinical follow-up with imaging study or repeat FNA. The
specimens evaluated with the standard CAST showed
slightly better cytohistologic concordance compared to
those in which the standard CAST was not used for inter-
pretation. We considered this as no significant impact on
the concordance rate since the difference was not statisti-
cally significant. Furthermore, the level of correlation
between cytology and histology demonstrated in the cur-
rent study is similar to those previously described.12,18
False positive diagnoses for follicular neoplasm repre-
sented most of the discrepant cases in the current study.
A considerable challenge in the diagnosis of Hashimoto’s
thyroiditis on specimens prepared by ThinPrep has been
previously reported.19,20 In our study, all five histology-
proven lymphocytic thyroiditis cases and three out of four
false negative cases were prepared by the ThinPrep
method.
After implementation of the standard CAST, all indi-
viduals made much fewer numbers of descriptive diagno-
ses. It is noted that the individuals reviewed different
cases with various levels of complexity and distribution
of case load varied among the individuals. Thus, it is not
optimal to compare RDD between individuals. The dra-
matic drop in RDD coupled with significantly fewer non-
diagnostic cases corresponded to the increased rates of
benign and follicular cell lesion diagnoses while the neo-
plastic diagnosis rate remained relatively constant. As the
RC was slightly improved after the implementation of the
CAST, the reduction of RDD and RND thus did not sacri-
fice the diagnostic accuracy. This reflects the effort by the
pathologists to adhere to the standard criteria and to use
more consistent terminology to provide a more definitive
diagnosis with less uncertainty whenever possible.
In conclusion, the reduction in RND and RDD follow-
ing implementing the standard CAST in FNA of thyroid
nodules provides more diagnostic consistency among the
pathologists thus a better and more uniform communica-
tion between the pathologists and the clinicians without
negatively impacting the diagnostic accuracy.
Acknowledgment
We are grateful for Brian Smola, C.T. for proof reading
our manuscript.
References
1. Gharib H. Fine needle aspiration biopsy of thyroid nodules: Advan-
tages, limitations, and effect. Mayo Clin Proc 1994;69:44–49.
2. Holleman F, Hoekstra JB, Ruitenberg HM. Evaluation of fine nee-
dle aspiration (FNA) cytology in the diagnosis of thyroid nodules.
Cytopathology 1995;6:168–175.
3. Mandreker SR, Nadkarni NS, Pinto RG, Menezes S. Role of fine
needle aspiration cytology as the initial modality in the investigation
of thyroid lesions. Acta Cytol 1995;39:898–904.
4. Zagorianakou P, Malamou-Mitsi V, Zagorianakou N, Stefanou D,
Tsatsoulis A, Agnantis NJ. The role of fine-needle aspiration biopsy
in the management of patients with thyroid nodules. In Vivo 2005;
19:605–609.
5. Baloch ZW, Tam D, Langer J, Mandel S, LiVolsi VA, Gupta P.
Ultrasound-guided fine needle aspiration biopsy of the thyroid: Role
of on-site assessment and multiple cytologic preparations. Diagn
Cytopathol 2000;23:425–429.
6. Eedes CR, Wang HH. Cost-effectiveness of immediate specimen
adequacy assessment of thyroid fine-needle aspirations. Am J Clin
Pathol 2004;121:64–89.
7. Ghofrani M, Beckman, Rimm D. The value of onsite adequacy
assessment of thyroid fine-needle aspiration is a function of operator
experience. Cancer (Cancer Cytopathol) 2006;108:110–113.
8. Kelly NP, Lim JC, DeJong S, Harmath C, Dudiak C, Wojcik E.
Specimen adequacy and diagnostic specificity of ultrasound-guided
fine needle aspirations of nonpalpable thyroid nodules. Diagn Cyto-
pathol 2006;34:188–190.
9. Zhu W, Michael CW. How important is on site adequacy assess-
ment for thyroid FNA? An evaluation of 883 cases. Diagn Cytopa-
thol 2007;35:183–186.
10. AACE/AME Task Force on Thyroid Nodules. American Associa-
tion of clinical endocrinologists and associazione medici endocrinol-
ogy medical guidelines for clinical practice for the diagnosis and
management of thyroid nodules. Endocr Pract 2006;12:63–102.
11. Methrotra P, Wiswanathan H, Johnson S, Wadehra V, Richardson
DL, Lennard TWJ. Ultrasound guidance improves the adequacy of
our preoperative thyroid cytology but not its accuracy. Cytopathol-
ogy 2006;17:137–144.
IMPACT OF CAST ON THYROID NODULE FNA
Diagnostic Cytopathology, Vol 36, No 3 165
Diagnostic Cytopathology DOI 10.1002/dc
12. Ylagan LR, Farkas T, Dehner LP. Fine needle aspiration of the thy-
roid: A cytohistologic correlation and study of discrepant cases.
Thyroid 2004;14:35–41.
13. The Papanicolaou Society of Cytopathology Task Force on Stand-
ards of Practice. Guidelines of the Papanicolaou Society of Cytopa-
thology for the examination of fine-needle aspiration specimens
from thyroid nodules. Diagn Cytopathol 1996;15:84–89.
14. Meko JB, Norton JA. Large cystic/solid thyroid nodules: A potential
false-negative fine-needle aspiration. Surgery 1995;118:996–1003.
15. Pu RT, Yang J, Wasserman PG, Bhuiya T, Griffith KA, Michael
CW. Does Hurthle cell lesion/neoplasm predict malignancy more
than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Diagn Cytopathol 2006;34:330–334.
16. Rimm DL, Stastny J, Rimm EB, Ayer S, Frable W. Comparison of
the cost of fine-needle aspiration and open surgical biopsy as meth-
ods for obtaining a pathologic diagnosis. Cancer (Cancer Cytopa-
thol) 1997;81:51–56.
17. Burch HB, Burman KD, Reed HL, Buckner L, Raber T, Ownbey
JL. Fine needle aspiration of thyroid nodules. Determinants of insuf-
ficiency rate and malignancy yield at thyroidectomy. Acta Cytol
1996;40:176–183.
18. Sidway MK, Del Vecchio DM, Knoll SM. Fine-needle aspiration of
thyroid nodules: Correlation between cytology and histology and
evaluation of discrepant cases. Cancer (Cancer Cytopathol) 1997;
81:253–259.
19. Biscotti CV, Hollow JA, Toddy SM, Easley KA. ThinPrep versus
conventional smears cytologic preparation in the analysis of thyroid
fine-needle aspiration specimens. Am J Clin Pathol 1995;104:150–
153.
20. Cochand-Priollet B, Prat JJ, Polivka M, Thienpont L, Dahan H,
Wassef M, Guillausseau PJ. Thyroid fine needle aspiration:
the morphological features of ThinPrep slide preparations.
Eighty cases with histological control. Cytopathology 2003;14:
343–349.
JING ET AL.
166 Diagnostic Cytopathology, Vol 36, No 3
Diagnostic Cytopathology DOI 10.1002/dc
